-
Mashup Score: 70Selecting First-Line Therapy for Metastatic Urothelial Carcinoma: Does ‘One Size Fit All’ or Is Customization Needed? - 9 day(s) ago
Enfortumab vedotin/pembrolizumab, gemcitabine-cisplatin/nivolumab, and the JAVELIN paradigm can all play a role as first-line therapy for appropriately selected patients with advanced urothelial carcinoma.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Read it now on PracticeUpdate.com
Source: www.practiceupdate.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Read it now on PracticeUpdate.com
Source: www.practiceupdate.comCategories: General Medicine News, Hem/OncsTweet
Advanced #urothelialcarcinoma #bladdercancer first-line treatment- my thoughts @ASCO - customization necessary since one size does not fit all (this is a ‘truism’ for almost anything?) https://t.co/yceJ5d4Aqr https://t.co/4UqWyLIMDQ https://t.co/7dCzHD3uJ1